Raymond James & Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,570
| Closed | -$1.21M | – | 4072 |
|
|
2021
Q1 | $1.21M | Sell |
5,570
-3,055
| -35% | -$663K | ﹤0.01% | 2373 |
|
|
2020
Q4 | $995K | Sell |
8,625
-13,966
| -62% | -$1.61M | ﹤0.01% | 2344 |
|
|
2020
Q3 | $2.2M | Buy |
22,591
+7,415
| +49% | +$722K | ﹤0.01% | 1702 |
|
|
2020
Q2 | $1.86M | Sell |
15,176
-120
| -0.8% | -$14.7K | ﹤0.01% | 1771 |
|
|
2020
Q1 | $1.34M | Buy |
15,296
+205
| +1% | +$17.9K | ﹤0.01% | 1802 |
|
|
2019
Q4 | $1.58M | Sell |
15,091
-1
| -0% | -$105 | ﹤0.01% | 1980 |
|
|
2019
Q3 | $1.74M | Sell |
15,092
-2,209
| -13% | -$254K | ﹤0.01% | 1859 |
|
|
2019
Q2 | $2.98M | Sell |
17,301
-948
| -5% | -$163K | ﹤0.01% | 1544 |
|
|
2019
Q1 | $3.08M | Sell |
18,249
-3,968
| -18% | -$669K | ﹤0.01% | 1497 |
|
|
2018
Q4 | $2.16M | Sell |
22,217
-3,474
| -14% | -$338K | ﹤0.01% | 1603 |
|
|
2018
Q3 | $4.44M | Buy |
25,691
+4,791
| +23% | +$828K | 0.01% | 1289 |
|
|
2018
Q2 | $2.92M | Buy |
20,900
+9,143
| +78% | +$1.28M | ﹤0.01% | 1526 |
|
|
2018
Q1 | $1.33M | Buy |
11,757
+3,293
| +39% | +$371K | ﹤0.01% | 1947 |
|
|
2017
Q4 | $1.12M | Buy |
8,464
+718
| +9% | +$94.8K | ﹤0.01% | 2059 |
|
|
2017
Q3 | $786K | Buy |
7,746
+763
| +11% | +$77.4K | ﹤0.01% | 2234 |
|
|
2017
Q2 | $700K | Buy |
6,983
+1,374
| +24% | +$138K | ﹤0.01% | 2234 |
|
|
2017
Q1 | $678K | Buy |
5,609
+1,711
| +44% | +$207K | ﹤0.01% | 2201 |
|
|
2016
Q4 | $436K | Buy |
3,898
+846
| +28% | +$94.6K | ﹤0.01% | 2405 |
|
|
2016
Q3 | $405K | Buy |
+3,052
| New | +$405K | ﹤0.01% | 2408 |
|